Target intelligence / Profile preview

HORMAD2 and MTMR3 antisense RNA 1 (HORMAD2-AS1)

Target
HORMAD2-AS1
Molecular classification
Long non-coding RNA, Antisense lncRNA, Other
01

Overview

HORMAD2 and MTMR3 antisense RNA 1 (HORMAD2-AS1) is a **long non-coding RNA (lncRNA)** that is transcribed in the antisense direction relative to the protein-coding HORMAD2 and MTMR3 loci on human chromosome 22q12.2[3][4][5][7]. This RNA does not encode a protein and functions as an antisense transcript, potentially regulating the expression of its neighboring or overlapping protein-coding genes through epigenetic modulation, transcriptional, or post-transcriptional mechanisms, as observed with other antisense lncRNAs[2][3]. Antisense lncRNAs as a class are increasingly recognized for their roles in the regulation of gene expression, and they have been implicated in cellular processes such as cell proliferation, apoptosis, and cancer biology, although direct experimental characterization for HORMAD2-AS1 itself appears limited at this time[2][3]. No evidence was identified to support HORMAD2-AS1 as a direct **therapeutic target** (such as a receptor, enzyme, transporter, or druggable protein). Its role is currently classified as a regulatory RNA molecule, and while antisense lncRNAs represent emerging targets for therapeutic intervention or biomarker discovery, HORMAD2-AS1 itself is not established as such in the literature as of this search[2][3][7].

Other names
MTMR3-AS1NONHSAG033653HORMAD2-AS1
02

Biological functions

Regulation of gene expressionEpigenetic modulationTranscriptional regulationTranslational controlOther
03

Disease associations

Cancer (general potential as many antisense lncRNAs are involved in cancer processes)Other

Beyond the preview

Go deeper on HORMAD2 and MTMR3 antisense RNA 1 (HORMAD2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HORMAD2 and MTMR3 antisense RNA 1 (HORMAD2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call